Boryung Pharmaceutical implements Cegedim Dendrite's Mobile Intelligence CRM solution

Cegedim Dendrite (Paris:CGM), the world's leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced today that Boryung Pharmaceutical Co., Ltd., has implemented Cegedim Dendrite's Mobile Intelligence™ CRM solution. Boryung Pharmaceutical is one of Korea's top 10 domestic pharmaceutical companies, and Cegedim Dendrite currently serves 14 of the industry's top-grossing companies in Korea.

“We are pleased we could provide Boryung Pharmaceutical with the tools in order to quickly and efficiently optimize their sales force”

Increasing Commercial Team's Effectiveness through Mobile Intelligence

Life Sciences companies need to maximize their customer relationships, capturing data easily and then synchronizing and consolidating it to generate meaningful reports. Advanced integrated segmentation and targeting increase the effectiveness of sales teams. Furthermore, efficiently sharing information within and between teams is essential.

Fully deployed in Korean, Mobile Intelligence™ enabled Boryung to achieve all their goals, optimizing sales and marketing and thus their overall performance. Boryung integrated Ethical Channel/Over-the-Counter business units and was freed from reliance on IT vendors who were not equipped to handle their projects.

Cegedim Dendrite worked with Boryung to quickly tailor the built-in configuration tools for its users, based on what their business process required. The tools can be altered to suit a certain region, country, group, or individual user. Unlike with other systems, the platform offers the same functions both offline and online.

"We chose Cegedim Dendrite's CRM system because of its significant added value over our previous SFA system," said Sung Soo Kim, CIO of Boryung Pharmaceutical. "Cegedim Dendrite offered a proven solution that was both scalable and industry-specific, and the tools are easy to use. Responsive and resourceful, they ensured the system was running smoothly in the timeframe planned."

"We are pleased we could provide Boryung Pharmaceutical with the tools in order to quickly and efficiently optimize their sales force," said Fred Jincheol Park, General Manager Korea of Cegedim Dendrite. "Our Life Sciences industry expertise, coupled with our experience in the Korean market helped us meet their needs and position them for greater growth and performance."

Source:

 Cegedim Dendrite

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combination therapy shows promising results in treating stage 3 melanoma